Biggest News Aggregation in the World
📰 Thomas Pedersen News

Page 2 - Thomas Pedersen News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Thomas Pedersen. Real-time updates on events, politics, business and more.

Initial Data from Allarity's Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical Benefit in DRP®-Selected Metastatic Breast Cancer Patients

Boston, MA — Allarity Therapeutics, Inc. , a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for...
United States Marie Foegh Mike Beyer Jamesg Cullem Thomas Pedersen Sam Brown Inc

Initial Data from Allarity's Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical ... | Business

Boston, MA (July 5, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for
United States Jamesg Cullem Mike Beyer Marie Foegh Thomas Pedersen Carrotize Pr Communications

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Initial Data from Allarity's Phase 2 Trial of IXEMPRA® Indicate Potential for Improved Clinical ... | Region

Boston, MA (July 5, 2023) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (Nasdaq: ALLR), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for
United States Marie Foegh Jamesg Cullem Thomas Pedersen Mike Beyer Allarity Therapeutics Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science